Research Article
Evaluation of Hepcidin Isoforms in Hemodialysis Patients by a Proteomic Approach Based on SELDI-TOF MS
Table 1
Clinical features and baseline laboratory data.
| | HD patients | Controls |
| Number of patients | 54 | 57 | Gender (Male/Female) | 29/25 | 38/21 | Age (years) | 67 14 | 35 15 | HFE genotype | | | wt/wt () | 35 | — | H63D/wt () | 14 | — | C282Y/wt () | 2 | — | Hemoglobin (g/dL) | 11.4 1.0 | 14.4 1.2 | Iron (g/dL) | 45.2 (43.1−60.0) | 96.4 (89.1–104.2) | Transferrin Saturation (%) | 20.5 8.3 | 28.9 9.0 | Ferritin (ng/mL) | 174 (156−258) | 90 (47−149) | CRP (mg/dL) | 4.7 (5.0−8.9) | 0.8 (0.4−1.4) | Interleukin-6 (pg/mL) | 6.8 5.8* | — |
|
|
range in normal subjects = 0.2–3.2 pg/mL.
|